The effects in vitro of TNF-α and its antagonist ‘etanercept’ on ejaculated human sperm
Nicola A. Pascarelli A C , Antonella Fioravanti A , Elena Moretti B , Giacomo M. Guidelli A , Lucia Mazzi B and Giulia Collodel B
+ Author Affiliations
- Author Affiliations
A Rheumatology Unit, Azienda Ospedaliera Universitaria Senese, Policlinico Le Scotte, Viale Bracci, 14, 53100, Siena, Italy.
B Department of Molecular and Developmental Medicine, University of Siena, Policlinico Le Scotte, Viale Bracci, 14, 53100, Siena, Italy.
C Corresponding author. Email: pascarelli@unisi.it
Reproduction, Fertility and Development 29(6) 1169-1177 https://doi.org/10.1071/RD16090
Submitted: 16 July 2015 Accepted: 16 March 2016 Published: 17 May 2016
Abstract
Tumour necrosis factor (TNF)-α is primarily involved in the regulation of cell proliferation and apoptosis; in addition it possesses pro-inflammatory properties. Anti-TNF-α strategies involve either administration of anti-TNF-α antibody or soluble TNF receptor to mop up circulating TNF-α. Etanercept, a recombinant human TNF-α receptor, was found to be effective in the treatment of rheumatoid arthritis. The impact of TNF-α inhibitors on human fertility is of notable interest. This in vitro study investigated the effect of different concentrations of TNF-α and etanercept used alone or in combination on sperm viability, motility, mitochondrial function, percentage of apoptosis and chromatin integrity in swim-up selected human spermatozoa. A negative effect of TNF-α (300 and 500 ng mL–1) and etanercept (from 800 µg mL–1 to 2000 µg mL–1) individually on sperm viability, motility, mitochondrial function, percentage of apoptotic spermatozoa and sperm DNA integrity was demonstrated. However, at concentrations of 100 and 200 µg mL–1, etanercept can block, in a significant way, the toxic effects of TNF-α (500 ng mL–1) on studied sperm characteristics. Our results confirm that TNF-α has a detrimental effect on sperm function and suggest, for the first time, that etanercept may counteract the in vitro toxic action of TNF-α. This data appears to be quite promising, although further studies, both in vivo and in vitro, are needed to understand the exact mechanism of action of TNF-α and TNF-α antagonists on sperm function.
Additional keywords: apoptosis, mitochondrial function.
References
Agarwal, A., Saleh, R. A., and Bedaiwy, M. A. (2003). Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil. Steril. 79, 829–843.| Role of reactive oxygen species in the pathophysiology of human reproduction.Crossref | GoogleScholarGoogle Scholar | 12749418PubMed |
Bejarano, I., Lozano, G. M., Ortiz, A., García, J. F., Paredes, S. D., Rodríguez, A. B., and Pariente, J. A. (2008). Caspase 3 activation in human spermatozoa in response to hydrogen peroxide and progesterone. Fertil. Steril. 90, 1340–1347.
| Caspase 3 activation in human spermatozoa in response to hydrogen peroxide and progesterone.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXhtlSrurbK&md5=0bf35ee00bfa0b8ee27a53f0ee560dd0CAS | 18155705PubMed |
Bian, J., Guo, X., Xiong, C., Li, J., Tian, Y., Ma, H., Zhang, Y., Nie, Y., Yu, L., and Xiao, L. (2004). Experimental study of the effect of rhTNF-alpha on human sperm mitochondrial function and motility in vitro. Zhonghua Nan Ke Xue 10, 415–419.
| 15267202PubMed |
Blandizzi, C., Gionchetti, P., Armuzzi, A., Caporali, R., Chimenti, S., Cimaz, R., Cimino, L., Lapadula, G., Lionetti, P., Marchesoni, A., Marcellusi, A., Mennini, F. S., Salvarani, C., and Girolomoni, G. (2014). The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases. Int. J. Immunopathol. Pharmacol. 27, 1–10.
| 1:STN:280:DC%2BC2cnnsl2rsQ%3D%3D&md5=d897f7f86f6cab1d6b5e9923ca456725CAS | 24774503PubMed |
Buch, J. P., Kolon, T. F., Maulik, N., Kreutzer, D. L., and Das, D. K. (1994). Cytokines stimulate lipid membrane peroxidation of human spermatozoa. Fertil. Steril. 62, 186–188.
| 1:STN:280:DyaK2c3ntlyltQ%3D%3D&md5=1a6f5a1f955dbcf9f5e56ff911a707f6CAS | 8005288PubMed |
Carrasquel, G., Camejo, M. I., Michelangeli, F., and Ruiz, M. C. (2013). Effect of tumour necrosis factor-α on the intracellular Ca2+ homeostasis in human spermatozoa. Am. J. Reprod. Immunol. 70, 153–161.
| Effect of tumour necrosis factor-α on the intracellular Ca2+ homeostasis in human spermatozoa.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXhsVCqt7bI&md5=24f08c51203768b8451dd7abf3e2ae67CAS | 23480259PubMed |
Castiglione, R., Salemi, M., Vicari, L. O., and Vicari, E. (2014). Relationship of semen hyperviscosity with IL-6, TNF-α, IL-10 and ROS production in seminal plasma of infertile patients with prostatitis and prostato-vesiculitis. Andrologia 46, 1148–1155.
| Relationship of semen hyperviscosity with IL-6, TNF-α, IL-10 and ROS production in seminal plasma of infertile patients with prostatitis and prostato-vesiculitis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXhvFShs7fK&md5=837929b2be79614dabb6dbe0598500e3CAS | 24329571PubMed |
Chopra, A., and Abdel-Nasser, A. (2008). Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract. Res. Clin. Rheumatol. 22, 583–604.
| Epidemiology of rheumatic musculoskeletal disorders in the developing world.Crossref | GoogleScholarGoogle Scholar | 18783739PubMed |
De, S. K., Chen, H. L., Pace, J. L., Hunt, J. S., Terranova, P. F., and Enders, G. C. (1993). Expression of tumour necrosis factor-alpha in mouse spermatogenic cells. Endocrinology 133, 389–396.
| 1:CAS:528:DyaK3sXltlOit7g%3D&md5=da10ab889c088adfc2c02acc3264255eCAS | 8319585PubMed |
Eisermann, J., Register, K. B., Strickler, R. C., and Collins, J. L. (1989). The effect of tumour necrosis factor on human sperm motility in vitro. J. Androl. 10, 270–274.
| The effect of tumour necrosis factor on human sperm motility in vitro.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaL1MXlsFWktrc%3D&md5=9d26c3ecbd26bdbb81b427714a016b2aCAS | 2777718PubMed |
Estrada, L. S., Champion, H. C., Wang, R., Rajasekaran, M., Hellstrom, W. J., Aggarwal, B., and Sikka, S. C. (1997). Effect of tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) on human sperm motility, viability and motion parameters. Int. J. Androl. 20, 237–242.
| Effect of tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) on human sperm motility, viability and motion parameters.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK2sXnslWqsrs%3D&md5=1c56a8d7647e05631d9124120d0665ffCAS | 9401827PubMed |
Faber, B. M., Chegini, N., Mahony, M. C., and Coddington, C. C. (2001). Macrophage secretory products and sperm zona pellucida binding. Obstet. Gynecol. 98, 668–673.
| 1:CAS:528:DC%2BD3MXntVWqsb4%3D&md5=85331332179cd1121e069273ffb98f8bCAS | 11576586PubMed |
Gallon, F., Marchetti, C., Jouy, N., and Marchetti, P. (2006). The functionality of mitochondria differentiates human spermatozoa with high and low fertilising capability. Fertil. Steril. 86, 1526–1530.
| The functionality of mitochondria differentiates human spermatozoa with high and low fertilising capability.Crossref | GoogleScholarGoogle Scholar | 16996512PubMed |
Gillan, L., Evans, G., and Maxwell, W. M. (2005). Flow cytometric evaluation of sperm parameters in relation to fertility potential. Theriogenology 63, 445–457.
| Flow cytometric evaluation of sperm parameters in relation to fertility potential.Crossref | GoogleScholarGoogle Scholar | 15626410PubMed |
Goffe, B. (2004). Etanercept (Enbrel) – an update. Skin Therapy Lett. 9, 1–4, 9.
| 1:STN:280:DC%2BD2M%2Fjt1emtA%3D%3D&md5=a7e6385aaa4a9e558ac6871502f249b1CAS | 15657632PubMed |
Grattendick, K. J., Nakashima, J. M., Feng, L., Giri, S. N., and Margolin, S. B. (2008). Effects of three anti-TNF-α drugs: etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitro. Int. Immunopharmacol. 8, 679–687.
| Effects of three anti-TNF-α drugs: etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitro.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXktlCqurs%3D&md5=c3ba8e3fceff1aec953cba27be7bdeb5CAS | 18387510PubMed |
Gruschwitz, M. S., Brezinschek, R., and Brezinschek, H. P. (1996). Cytokine levels in the seminal plasma of infertile males. J. Androl. 17, 158–163.
| 1:STN:280:DyaK28zgtlehug%3D%3D&md5=5f177e40fa06df04d8bab356e095baceCAS | 8723440PubMed |
Guazzone, V. A., Jacobo, P., Theas, M. S., and Lustig, L. (2009). Cytokines and chemokines in testicular inflammation: a brief review. Microsc. Res. Tech. 72, 620–628.
| Cytokines and chemokines in testicular inflammation: a brief review.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXhtVOnurjJ&md5=05109a385a05f8c8868a8410183d3e1fCAS | 19263422PubMed |
Haidl, F., Haidl, G., Oltermann, I., and Allam, J. P. (2015). Seminal parameters of chronic male genital inflammation are associated with disturbed sperm DNA integrity. Andrologia 47, 464–469.
| Seminal parameters of chronic male genital inflammation are associated with disturbed sperm DNA integrity.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXlvV2hurs%3D&md5=8477685bbc6ac3b0ab5d1492f493095aCAS | 25708510PubMed |
Havrylyuk, A., Chopyak, V., Boyko, Y., Kril, I., and Kurpisz, M. (2015). Cytokines in the blood and semen of infertile patients. Cent. Eur. J. Immunol. 40, 337–344.
| Cytokines in the blood and semen of infertile patients.Crossref | GoogleScholarGoogle Scholar | 26648778PubMed |
Hedger, M. P., and Meinhardt, A. (2003). Cytokines and the immune–testicular axis. J. Reprod. Immunol. 58, 1–26.
| Cytokines and the immune–testicular axis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXhsVCntLo%3D&md5=61261ab71d29845d50aeacf341e5ab0fCAS | 12609522PubMed |
Hong, C. Y., Park, J. H., Ahn, R. S., Im, S. Y., Choi, H. S., Soh, J., Mellon, S. H., and Lee, K. (2004). Molecular mechanism of suppression of testicular steroidogenesis by pro-inflammatory cytokine tumour necrosis factor alpha. Mol. Cell. Biol. 24, 2593–2604.
| Molecular mechanism of suppression of testicular steroidogenesis by pro-inflammatory cytokine tumour necrosis factor alpha.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXis1ems7s%3D&md5=449a23a5f1b6356b4e7910dc0f10f5b3CAS | 15024051PubMed |
Idriss, H. T., and Naismith, J. H. (2000). TNF-alpha and the TNF receptor superfamily: structure–function relationship(s). Microsc. Res. Tech. 50, 184–195.
| TNF-alpha and the TNF receptor superfamily: structure–function relationship(s).Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3cXmtVeqtbk%3D&md5=06646af758f64fc92f206a2995043916CAS | 10891884PubMed |
Jain, A., and Singh, J. A. (2013). Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature. Immunotherapy 5, 265–299.
| Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXjtF2qsLc%3D&md5=0f1f303373390651191b9a722f70f5cfCAS | 23444956PubMed |
Koçak, I., Yenisey, C., Dündar, M., Okyay, P., and Serter, M. (2002). Relationship between seminal plasma interleukin-6 and tumour necrosis factor alpha levels with semen parameters in fertile and infertile men. Urol. Res. 30, 263–267.
| Relationship between seminal plasma interleukin-6 and tumour necrosis factor alpha levels with semen parameters in fertile and infertile men.Crossref | GoogleScholarGoogle Scholar | 12202945PubMed |
La Montagna, G., Malesci, D., Buono, R., and Valentini, G. (2005). Asthenoazoospermia in patients receiving anti tumour necrosis factor alpha agents. Ann. Rheum. Dis. 64, 1667.
| Asthenoazoospermia in patients receiving anti tumour necrosis factor alpha agents.Crossref | GoogleScholarGoogle Scholar |
Lampiao, F., and du Plessis, S. S. (2008). TNF-alpha and IL-6 affect human sperm function by elevating nitric oxide production. Reprod. Biomed. Online 17, 628–631.
| TNF-alpha and IL-6 affect human sperm function by elevating nitric oxide production.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXhsFektbvO&md5=fce1d2ac9f32e7f93957eeb06e3a9825CAS | 18983746PubMed |
Marchetti, C., Jouy, N., Leroy-Martin, B., Defossez, A., Formstecher, P., and Marchetti, P. (2004). Comparison of four fluorochromes for the detection of the inner mitochondrial membrane potential in human spermatozoa and their correlation with sperm motility. Hum. Reprod. 19, 2267–2276.
| Comparison of four fluorochromes for the detection of the inner mitochondrial membrane potential in human spermatozoa and their correlation with sperm motility.Crossref | GoogleScholarGoogle Scholar | 15256505PubMed |
Markatseli, T. E., Papagoras, C., Kaltsonoudis, E., Voulgari, P. V., and Drosos, A. A. (2014). Reply to the comment “Effect of Infliximab on Male Fertility” by Younis et al. Joint Bone Spine 81, 103.
| Reply to the comment “Effect of Infliximab on Male Fertility” by Younis et al.Crossref | GoogleScholarGoogle Scholar | 24439962PubMed |
Maxwell, L. J., Zochling, J., Boonen, A., Singh, J. A., Veras, M. M., Tanjong Ghogomu, E., Benkhalti Jandu, M., Tugwell, P., and Wells, G. A. (2015). TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst. Rev. 4, CD005468.
| 25887212PubMed |
Micu, M. C., Micu, R., Surd, S., Gîrlovanu, M., Bolboacă, S. D., and Ostensen, M. (2014). TNF-α inhibitors do not impair sperm quality in males with ankylosing spondylitis after short-term or long-term treatment. Rheumatology 53, 1250–1255.
| TNF-α inhibitors do not impair sperm quality in males with ankylosing spondylitis after short-term or long-term treatment.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXhtVKhsLzJ&md5=c1838877e1e442b1ecdbbb3916a952f0CAS | 24599921PubMed |
Moretti, E., Cosci, I., Spreafico, A., Serchi, T., Cuppone, A. M., and Collodel, G. (2009). Semen characteristics and inflammatory mediators in infertile men with different clinical diagnoses. Int. J. Androl. 32, 637–646.
| Semen characteristics and inflammatory mediators in infertile men with different clinical diagnoses.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXhsFOqt7vL&md5=ba856537d7118a665fecc1ee81b85f5cCAS | 18710409PubMed |
Murdaca, G., Spanò, F., Contatore, M., Guastalla, A., Magnani, O., and Puppo, F. (2014). Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opin. Drug Saf. 13, 649–661.
| Efficacy and safety of etanercept in chronic immune-mediated disease.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXms1Wrtb4%3D&md5=4944b125b9417ab1736fe4439bbac59dCAS | 24654562PubMed |
Nadler, R. B., Koch, A. E., Calhoun, E. A., Campbell, P. L., Pruden, D. L., Bennett, C. L., Yarnold, P. R., and Schaeffer, A. J. (2000). IL-1 beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J. Urol. 164, 214–218.
| IL-1 beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3cXksVCku7w%3D&md5=5fc23db18bd44cc4578d0bd8d4803b5fCAS | 10840462PubMed |
Nestorov, I., Zitnik, R., DeVries, T., Nakanishi, A. M., Wang, A., and Banfield, C. (2006). Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis. Br. J. Clin. Pharmacol. 62, 435–445.
| Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD28Xht1ehtbvF&md5=c2ad03832b86acc8d19b37b30bee7ca8CAS | 16995864PubMed |
Nickel, J. C. (2001). Special report on prostatitis: state of the art: highlights of the Third Annual International Prostatitis Collaborative Network Meeting October 23–25, Washington, DC. Rev. Urol. 3, 94–98.
| 1:STN:280:DC%2BD28rmtVOmtA%3D%3D&md5=afc2bdb4e38b922de980f67f7a723e3fCAS | 16985696PubMed |
Noriega, J., Bedaiwy, M., Sharma, R., and Falcone, T. (2004). Effect of tumour necrosis factor-alpha blocker (infliximab) on blastocyst development in vitro. Fertil. Steril. 81, 1704–1706.
| Effect of tumour necrosis factor-alpha blocker (infliximab) on blastocyst development in vitro.Crossref | GoogleScholarGoogle Scholar | 15193503PubMed |
Østensen, M., Khamashta, M., Lockshin, M., Parke, A., Brucato, A., Carp, H., Doria, A., Rai, R., Meroni, P., Cetin, I., et al. (2006). Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res. Ther. 8, 209.
| Anti-inflammatory and immunosuppressive drugs and reproduction.Crossref | GoogleScholarGoogle Scholar | 16712713PubMed |
Paasch, U., Grunewald, S., Fitzl, G., and Glander, H. J. (2003). Deterioration of plasma membrane is associated with activated caspases in human spermatozoa. J. Androl. 24, 246–252.
| Deterioration of plasma membrane is associated with activated caspases in human spermatozoa.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXmsFCmsrY%3D&md5=077a0ae3f6c9f113ef245167382c7b8bCAS | 12634312PubMed |
Paoli, D., Gallo, M., Rizzo, F., Baldi, E., Francavilla, S., Lenzi, A., Lombardo, F., and Gandini, L. (2011). Mitochondrial membrane potential profile and its correlation with increasing sperm motility. Fertil. Steril. 95, 2315–2319.
| Mitochondrial membrane potential profile and its correlation with increasing sperm motility.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXmsFWnsL4%3D&md5=91e984c52c40b3b3ea64832da7c12c19CAS | 21507394PubMed |
Paschou, S., Voulgari, P. V., Vrabie, I. G., Saougou, I. G., and Drosos, A. A. (2009). Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab. J. Rheumatol. 36, 351–354.
| 19040305PubMed |
Pentikäinen, V., Erkkilä, K., Suomalainen, L., Otala, M., Pentikäinen, M. O., Parvinen, M., and Dunkel, L. (2001). TNF-alpha downregulates the Fas ligand and inhibits germ-cell apoptosis in the human testis. J. Clin. Endocrinol. Metab. 86, 4480–4488.
| 11549697PubMed |
Perdichizzi, A., Nicoletti, F., La Vignera, S., Barone, N., D’Agata, R., Vicari, E., and Calogero, A. E. (2007). Effects of tumour necrosis factor-α on human sperm motility and apoptosis. J. Clin. Immunol. 27, 152–162.
| Effects of tumour necrosis factor-α on human sperm motility and apoptosis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXitlCrsLo%3D&md5=8c1312c785584585872a4b4b5d786d1bCAS | 17308869PubMed |
Politch, J. A., Tucker, L., Bowman, F. P., and Anderson, D. J. (2007). Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum. Reprod. 22, 2928–2935.
| Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXht1Shu7fK&md5=ff70eb7d0599341c74d0691644927143CAS | 17855405PubMed |
Pontari, M. A. (2002). Inflammation and anti-inflammatory therapy in chronic prostatitis. Urology 60, 29–33.
| Inflammation and anti-inflammatory therapy in chronic prostatitis.Crossref | GoogleScholarGoogle Scholar |
Puchner, R., Danninger, K., Puchner, A., and Pieringer, H. (2012). Impact of TNF-blocking agents on male sperm characteristics and pregnancy outcomes in fathers exposed to TNF-blocking agents at time of conception. Clin. Exp. Rheumatol. 30, 765–767.
| 22935608PubMed |
Ramonda, R., Foresta, C., Ortolan, A., Bertoldo, A., Oliviero, F., Lorenzin, M., Pizzol, D., Punzi, L., and Garolla, A. (2014). Influence of tumour necrosis factor-α inhibitors on testicular function and semen in spondyloarthritis patients. Fertil. Steril. 101, 359–365.
| Influence of tumour necrosis factor-α inhibitors on testicular function and semen in spondyloarthritis patients.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXitVWju7zM&md5=0dd5fc67b533235cd4d990bc29b8798bCAS | 24332378PubMed |
Rezvani, A., and Ozaras, N. (2008). Infertility improved by etanercept in ankylosing spondylitis. Indian J. Pharmacol. 40, 276–277.
| Infertility improved by etanercept in ankylosing spondylitis.Crossref | GoogleScholarGoogle Scholar | 21279185PubMed |
Said, T. M., Agarwal, A., Falcone, T., Sharma, R. K., Bedaiwy, M. A., and Li, L. (2005). Infliximab may reverse the toxic effects induced by tumour necrosis factor alpha in human spermatozoa: an in vitro model. Fertil. Steril. 83, 1665–1673.
| Infliximab may reverse the toxic effects induced by tumour necrosis factor alpha in human spermatozoa: an in vitro model.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2MXmt1Wlurs%3D&md5=05b5d3bfff3768dbee751aa60c7334b4CAS | 15950634PubMed |
Saougou, I., Markatseli, T. E., Papagoras, C., Kaltsonoudis, E., Voulgari, P. V., and Drosos, A. A. (2013). Fertility in male patients with sieronegative spondyloartropathies treated with infliximab. Joint Bone Spine 80, 34–37.
| Fertility in male patients with sieronegative spondyloartropathies treated with infliximab.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xnt1Cht7c%3D&md5=8afe6df8ca14f44aca4b5f7d425e30cbCAS | 22575067PubMed |
Sarkar, O., Bahrainwala, J., Chandrasekaran, S., Kothari, S., Mathur, P. P., and Agarwal, A. (2011). Impact of inflammation on male fertility. Front. Biosci. 3, 89–95.
| Impact of inflammation on male fertility.Crossref | GoogleScholarGoogle Scholar |
Sfikakis, P. P. (2010). The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr. Dir. Autoimmun. 11, 180–210.
| The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXnvFWmsb8%3D&md5=1201d123adc2e87897b3340b95e22c6aCAS | 20173395PubMed |
Siebert, S., Tsoukas, A., Robertson, J., and McInnes, I. (2015). Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol. Rev. 67, 280–309.
| Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXlsFSjtbg%3D&md5=bafa4d2ece7e51592e2d08af56800f36CAS | 25697599PubMed |
Suominen, J. S., Wang, Y., Kaipia, A., and Toppari, J. (2004). Tumour necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist. Eur. J. Endocrinol. 151, 629–640.
| Tumour necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXhtVGlurzN&md5=6cae101ee0d8b496eab69708614010d5CAS | 15538942PubMed |
Tejada, R. I., Mitchell, J. C., Norman, A., Marik, J. J., and Friedman, S. (1984). A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. Fertil. Steril. 42, 87–91.
| 1:STN:280:DyaL2c3gvV2quw%3D%3D&md5=0bbf7f7371c111bb9143413da88f4488CAS | 6724015PubMed |
Villiger, P. M., Caliezi, G., Cottin, V., Förger, F., Senn, A., and Østensen, M. (2010). Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann. Rheum. Dis. 69, 1842–1844.
| Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhtlems7jM&md5=055766785b950e2ba3d2e82810e78612CAS | 20610443PubMed |
Wildi, L. M., and Haraoui, B. (2012). Reversible male infertility under treatment with an anti-TNF-α agent: a case report. Ann. Rheum. Dis. 71, 473–474.
| Reversible male infertility under treatment with an anti-TNF-α agent: a case report.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38Xlt1Wlsb8%3D&md5=b70a504420215c7d947f16c6e93bed06CAS | 22138196PubMed |
World Health Organization (2010) ‘WHO Laboratory Manual for the Examination and Processing of Human Semen’. 5th edn. (WHO Press: Geneva.)
Xixi, M. A., and Shengoqian, X. U. (2013). TNF inhibitor therapy for rheumatoid arthritis. Biomed. Rep. 1, 177–184.
Younis, S., Rimar, D., Slobodin, G., Boulman, N., Rozenbaum, M., and Rosner, I. (2014). Effect of infliximab on male fertility: comment on the article “Fertility in male patients with seronegative spondyloarthropathies treated with infliximab” by Saougou et al., Joint Bone Spine 2013;80, 34–37. Joint Bone Spine 81, 102–103.
| Effect of infliximab on male fertility: comment on the article “Fertility in male patients with seronegative spondyloarthropathies treated with infliximab” by Saougou et al., Joint Bone Spine 2013;80, 34–37.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXhvF2rsb%2FM&md5=d37d3f4e074dabdad2fd3fdaf806e2f8CAS | 24331412PubMed |
